135525-78-9 Usage
Molecular Structure
Includes a benzoxazolylmethylamino group and a pyridinone group
Synthesis
Achieved through multiple chemical reactions
Usage
Employed in research and pharmaceutical applications
Potential Medicinal Properties
May exhibit antimicrobial, antioxidant, or anti-inflammatory effects
Biological Activities
Under study for various therapeutic uses
Complex Structure Advantage
Potential for binding to specific biological targets
Drug Development
Promising candidate for pharmaceutical development
Applications in Research
Potential uses in chemical research and development of new materials
Check Digit Verification of cas no
The CAS Registry Mumber 135525-78-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,5,5,2 and 5 respectively; the second part has 2 digits, 7 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 135525-78:
(8*1)+(7*3)+(6*5)+(5*5)+(4*2)+(3*5)+(2*7)+(1*8)=129
129 % 10 = 9
So 135525-78-9 is a valid CAS Registry Number.
135525-78-9Relevant articles and documents
The synthesis of several tritiated non-nucleoside, HIV-1 reverse transcriptase inhibitors
Hamill, Terence G.,Brenner, Nancy J.,Eng, Wai-Si,Burns, H. Donald
, p. 319 - 327 (2007/10/03)
The synthesis of three tritiated reverse transcriptase inhibitors is described herein. These compounds contained the benzoxazole ring linked to a 2-pyridinone ring by an aminomethylene group. The tritiated compounds were synthesized by hydrogenolysis of bromobenzoxazole precursors. The final tritiated compounds had specific activities ranging from 3-10 Cl/mmol.
2-pyridinone derivatives: A new class of nonucleoside, HIV-1-specific reverse transcriptase inhibitors [3]
Saari,Hoffman,Wai,Fisher,Rooney,Smith,Thomas,Goldman,O'Brien,Nunberg,Quintero,Schleif,Emini,Stern,Anderson
, p. 2922 - 2925 (2007/10/02)
-
